Drug Discovery

Labs of the future will use VR, AR, AI and more. But we must overcome the barriers of implementation, including cultural resistance.

The FDA Modernization Act opens the door for more innovative alternatives to animal testing for drug discovery and development

The challenges of complex disorders require collaboration, embracing technological developments, and acknowledging the gaps in access to medicine

Three companies – Cardinal Health, REGENXBIO, and Beacon Therapeutics – help us explore gene therapy development in the ophthalmic space

Machine learning has significant promise, but we should never overlook the importance of the human factor.

Can genetically engineering yeast be used to produce safe and scalable schizophrenia plant-inspired drugs?

Our roundup of some of our thoughtful and inspiring video interviews and roundtables from the past year.

Cerevel Therapeutics' Emraclidine - in development for schizophrenia and Alzheimer’s disease psychosis - yields positive results in phase Ib trial

Exploring the potential of hybrid peptide-DNA nanostructures and artificial life

How multi-omics and AI-driven target identification can drive the future of personalized medicine